
CrowdStrike Holdings Inc. ($CRWD) has garnered attention as a recommended buy by financial commentator Jim Cramer during his recent Lightning Round segment on CNBC. Cramer indicated that the stock is a good entry point, particularly after observing a trendline hold and a bounce above the $308 mark. Following this analysis, traders noted a significant uptick in options activity, with next week's $320 calls rising over 30%. Cramer reiterated his bullish stance, categorizing CrowdStrike as a strong buy, alongside other stocks such as Vertex Pharmaceuticals ($VRTX). This endorsement aligns with market trends, as investors respond positively to the stock's recent performance.
.@jimcramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed. On Wednesday, he told one caller to buy Vertex Pharmaceuticals. https://t.co/W39HAEspM5
🚨 Cramer’s Top Picks! $VRTX $CME $TROW $MU https://t.co/qQBFenlMXu
Cramer's Lightning Round: Vertex Pharmaceuticals is a buy https://t.co/HaAwxEDt8G

